What Researchers Did
Researchers treated 15 patients with chronic progressive Multiple Sclerosis with hyperbaric oxygen therapy for 20 daily exposures followed by monthly exposures over a 24-month follow-up period.
What They Found
No objective benefit was observed from hyperbaric oxygen therapy in moderating the progression of multiple sclerosis over the 24-month study period. However, a subjective improvement in bladder control was reported by 8 patients in the short-term and by 5 patients in the long-term follow-up. Electrophysiological results showed no significant variations after the initial 20 exposures.
Canadian Relevance
This study has no direct Canadian connection as it was conducted in Italy.
Study Limitations
A limitation of this study is its small sample size of 15 patients, which may affect the generalizability of the findings.